Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies.

Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP.

Br J Anaesth. 2019 Jan;122(1):19-31. doi: 10.1016/j.bja.2018.09.010. Epub 2018 Oct 25. Review.

PMID:
30579402
2.

Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data.

Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ.

Microbiome. 2018 Dec 17;6(1):226. doi: 10.1186/s40168-018-0605-2.

3.

Host Energy Source Is Important for Disease Tolerance to Malaria.

Cumnock K, Gupta AS, Lissner M, Chevee V, Davis NM, Schneider DS.

Curr Biol. 2018 May 21;28(10):1635-1642.e3. doi: 10.1016/j.cub.2018.04.009. Epub 2018 May 10.

4.

Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.

Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL.

Nat Microbiol. 2018 Jun;3(6):662-669. doi: 10.1038/s41564-018-0150-6. Epub 2018 Apr 23.

5.

A spatial gradient of bacterial diversity in the human oral cavity shaped by salivary flow.

Proctor DM, Fukuyama JA, Loomer PM, Armitage GC, Lee SA, Davis NM, Ryder MI, Holmes SP, Relman DA.

Nat Commun. 2018 Feb 14;9(1):681. doi: 10.1038/s41467-018-02900-1.

6.

Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era.

Doyle LW, Adams AM, Robertson C, Ranganathan S, Davis NM, Lee KJ, Cheong JL; Victorian Infant Collaborative Study Group.

Thorax. 2017 Aug;72(8):712-719. doi: 10.1136/thoraxjnl-2016-208524. Epub 2016 Sep 6.

PMID:
27601432
7.

Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.

Yang Z, Ramsey J, Hamza T, Zhang Y, Li S, Yfantis HG, Lee D, Hernandez LD, Seghezzi W, Furneisen JM, Davis NM, Therien AG, Feng H.

Infect Immun. 2015 Feb;83(2):822-31. doi: 10.1128/IAI.02897-14. Epub 2014 Dec 8.

8.

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, Drobot L, Rakus D, Gizak A, Laidler P, Dulińska-Litewka J, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Montalto G, Cervello M, Fitzgerald TL, Demidenko Z, Martelli AM, Cocco L, Steelman LS, McCubrey JA.

Oncotarget. 2014 Jul 15;5(13):4603-50. Review.

9.

GSK-3 as potential target for therapeutic intervention in cancer.

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M.

Oncotarget. 2014 May 30;5(10):2881-911. Review.

10.

Targeting breast cancer initiating cells: advances in breast cancer research and therapy.

McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Libra M, Nicoletti F, D'Assoro AB, Cocco L, Martelli AM, Steelman LS.

Adv Biol Regul. 2014 Sep;56:81-107. doi: 10.1016/j.jbior.2014.05.003. Epub 2014 May 22. Review.

PMID:
24913694
11.

X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.

Báez-Santos YM, Barraza SJ, Wilson MW, Agius MP, Mielech AM, Davis NM, Baker SC, Larsen SD, Mesecar AD.

J Med Chem. 2014 Mar 27;57(6):2393-412. doi: 10.1021/jm401712t. Epub 2014 Mar 14.

12.

Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.

Sokolosky M, Chappell WH, Stadelman K, Abrams SL, Davis NM, Steelman LS, McCubrey JA.

Cell Cycle. 2014;13(5):820-33. doi: 10.4161/cc.27728. Epub 2014 Jan 9.

13.

Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy.

McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Basecke J, Libra M, Nicoletti F, Cocco L, Martelli AM, Steelman LS.

Adv Biol Regul. 2014 Jan;54:176-96. doi: 10.1016/j.jbior.2013.09.013. Epub 2013 Oct 8. Review. No abstract available.

PMID:
24169510
14.

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Cocco L, Cervello M, Martelli AM.

Leukemia. 2014 Jan;28(1):15-33. doi: 10.1038/leu.2013.184. Epub 2013 Jun 19. Review.

15.

Advances in targeting signal transduction pathways.

McCubrey JA, Steelman LS, Chappell WH, Sun L, Davis NM, Abrams SL, Franklin RA, Cocco L, Evangelisti C, Chiarini F, Martelli AM, Libra M, Candido S, Ligresti G, Malaponte G, Mazzarino MC, Fagone P, Donia M, Nicoletti F, Polesel J, Talamini R, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Michele M, Tafuri A, Dulińska-Litewka J, Laidler P, D'Assoro AB, Drobot L, Umezawa D, Montalto G, Cervello M, Demidenko ZN.

Oncotarget. 2012 Dec;3(12):1505-21. Review.

16.

TCDD inhibition of canonical Wnt signaling disrupts prostatic bud formation in mouse urogenital sinus.

Branam AM, Davis NM, Moore RW, Schneider AJ, Vezina CM, Peterson RE.

Toxicol Sci. 2013 May;133(1):42-53. doi: 10.1093/toxsci/kft027. Epub 2013 Feb 20.

17.

The maturational trajectories of NREM and REM sleep durations differ across adolescence on both school-night and extended sleep.

Feinberg I, Davis NM, de Bie E, Grimm KJ, Campbell IG.

Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R533-40. doi: 10.1152/ajpregu.00532.2011. Epub 2011 Nov 23.

18.

Topographic differences in the adolescent maturation of the slow wave EEG during NREM sleep.

Feinberg I, de Bie E, Davis NM, Campbell IG.

Sleep. 2011 Mar 1;34(3):325-33.

19.

Adolescent changes in homeostatic regulation of EEG activity in the delta and theta frequency bands during NREM sleep.

Campbell IG, Darchia N, Higgins LM, Dykan IV, Davis NM, de Bie E, Feinberg I.

Sleep. 2011 Jan 1;34(1):83-91.

20.

Evaluation of an acute focal epidural mass model to characterize the intracranial pressure-volume relationship in healthy Beagles.

Packer RA, Simmons JP, Davis NM, Constable PD.

Am J Vet Res. 2011 Jan;72(1):103-8. doi: 10.2460/ajvr.72.1.103.

PMID:
21194342
21.

The chirality of gut rotation derives from left-right asymmetric changes in the architecture of the dorsal mesentery.

Davis NM, Kurpios NA, Sun X, Gros J, Martin JF, Tabin CJ.

Dev Cell. 2008 Jul;15(1):134-45. doi: 10.1016/j.devcel.2008.05.001.

22.

The direction of gut looping is established by changes in the extracellular matrix and in cell:cell adhesion.

Kurpios NA, Ibañes M, Davis NM, Lui W, Katz T, Martin JF, Izpisúa Belmonte JC, Tabin CJ.

Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8499-506. doi: 10.1073/pnas.0803578105. Epub 2008 Jun 23.

23.

Developmental coordination disorder at 8 years of age in a regional cohort of extremely-low-birthweight or very preterm infants.

Davis NM, Ford GW, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group.

Dev Med Child Neurol. 2007 May;49(5):325-30.

24.

Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence.

Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM.

Pediatrics. 2006 Jul;118(1):108-13.

PMID:
16818555
25.

Depression in children and adolescents.

Davis NM.

J Sch Nurs. 2005 Dec;21(6):311-7. Review.

PMID:
16285840
26.

Extremely low birth weight and body size in early adulthood.

Doyle LW, Faber B, Callanan C, Ford GW, Davis NM.

Arch Dis Child. 2004 Apr;89(4):347-50.

27.
28.

Evaluating best management practices at an urban golf course.

Davis NM, Lydy MJ.

Environ Toxicol Chem. 2002 May;21(5):1076-84.

PMID:
12013130
29.

Cloning and expression of a novel cysteine-rich secreted protein family member expressed in thyroid and pancreatic mesoderm within the chicken embryo.

Smith DM, Collins-Racie LA, Marigo VA, Roberts DJ, Davis NM, Hartmann C, Schweitzer R, LaVallie ER, Gamer L, McCoy J, Tabin CJ.

Mech Dev. 2001 Apr;102(1-2):223-6.

30.

Auditory function at 14 years of age of very-low-birthweight.

Davis NM, Doyle LW, Ford GW, Keir E, Michael J, Rickards AL, Kelly EA, Callanan C.

Dev Med Child Neurol. 2001 Mar;43(3):191-6.

31.

Birth weight <1501 g and respiratory health at age 14.

Doyle LW, Cheung MM, Ford GW, Olinsky A, Davis NM, Callanan C.

Arch Dis Child. 2001 Jan;84(1):40-44.

32.

Harvey A. K. Whitney Lecture. Initiatives for reducing medication errors: the time is now.

Davis NM.

Am J Health Syst Pharm. 2000 Aug 15;57(16):1487-92. No abstract available.

PMID:
10965394
33.

Very low birth weight and growth into adolescence.

Ford GW, Doyle LW, Davis NM, Callanan C.

Arch Pediatr Adolesc Med. 2000 Aug;154(8):778-84.

PMID:
10922273
34.

Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams.

Doyle LW, Ford GW, Rickards AL, Kelly EA, Davis NM, Callanan C, Olinsky A.

Pediatrics. 2000 Jul;106(1):E2.

PMID:
10878171
35.

Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight.

Davis PG, Doyle LW, Rickards AL, Kelly EA, Ford GW, Davis NM, Callanan C.

J Paediatr Child Health. 2000 Feb;36(1):47-50.

PMID:
10723691
36.

Survival, cranial ultrasound and cerebral palsy in very low birthweight infants: 1980s versus 1990s.

Doyle LW, Betheras FR, Ford GW, Davis NM, Callanan C.

J Paediatr Child Health. 2000 Feb;36(1):7-12.

PMID:
10723683
37.

Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children.

Doyle LW, Ford GW, Davis NM, Callanan C.

Clin Sci (Lond). 2000 Feb;98(2):137-42.

PMID:
10657267
38.

Changes in lung function between age 8 and 14 years in children with birth weight of less than 1,501 g.

Doyle LW, Chavasse R, Ford GW, Olinsky A, Davis NM, Callanan C.

Pediatr Pulmonol. 1999 Mar;27(3):185-90.

PMID:
10213257
39.

Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse.

Ware ML, Fox JW, González JL, Davis NM, Lambert de Rouvroit C, Russo CJ, Chua SC Jr, Goffinet AM, Walsh CA.

Neuron. 1997 Aug;19(2):239-49.

40.

Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain.

Mastick GS, Davis NM, Andrew GL, Easter SS Jr.

Development. 1997 May;124(10):1985-97.

41.

Axon tracts correlate with netrin-1a expression in the zebrafish embryo.

Lauderdale JD, Davis NM, Kuwada JY.

Mol Cell Neurosci. 1997;9(4):293-313.

PMID:
9268507
42.

A healthcare controlled vocabulary. A case is made for standardizing medical terminology.

Davis NM.

J Am Assoc Med Transcr. 1996 May-Jun;15(3):33, 36, 38. No abstract available.

PMID:
10184538
43.

Sterile cockpit.

Davis NM, Cohen MR.

Am Pharm. 1995 Dec;NS35(12):11. No abstract available.

PMID:
8546068
44.

Computer-generated prescription orders.

Davis NM, Cohen MR.

Am Pharm. 1995 Sep;NS35(9):10. No abstract available.

PMID:
7484808
45.

Repackaging bulk chemicals.

Cohen MR, Davis NM.

Am Pharm. 1995 Aug;NS35(8):11; 39. No abstract available.

PMID:
7677049
46.

Distractions as a cause of error.

Davis NM, Cohen MR.

Am Pharm. 1995 Jun;NS35(6):11. No abstract available.

PMID:
7661092
47.

Focusing on the causes of dispensing errors.

Cohen MR, Davis NM.

Am Pharm. 1995 May;NS35(5):16-7. No abstract available.

PMID:
7611132
48.

Preventing omission errors.

Davis NM.

Am J Nurs. 1995 Apr;95(4):17. No abstract available.

PMID:
7755023
49.

Med errors. Potassium perils.

Davis NM.

Am J Nurs. 1995 Mar;95(3):14. No abstract available.

PMID:
7717430
50.

Changing how pharmacists think about errors.

Davis NM, Cohen MR.

Am Pharm. 1995 Feb;NS35(2):11, 46. No abstract available.

PMID:
7900645

Supplemental Content

Loading ...
Support Center